Is an NCD the Right Move for Your Technology? Lessons from CMS’s Final Decision on Renal Denervation
Published on: 29/10/2025
Learn when to pursue a National Coverage Determination (NCD) and what CMS’s renal denervation decision means for MedTech reimbursement and evidence strategy.
Payer CoverageEvidence PlanningCommercialization
Why a Payer Dossier Matters, Even in the Early Days
Published on: 16/09/2025
Discover why payer dossiers are critical for MedTech startups, even in early stages. Learn how they guide evidence development, coding, and reimbursement strategy.
Payer CoverageEvidence Planning
The Myth of the Perfect Study for U.S. Market Access
Published on: 12/08/2025
One study rarely unlocks full payer coverage. Learn why U.S. market access requires a portfolio of evidence, strategic sequencing, and payer-specific insights.
Evidence Planning
Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies
Published on: 19/03/2025
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
Coding and PaymentEvidence PlanningFeatured
